Management of severe pulmonary Langerhans cell histiocytosis in children

OS Eckstein, JG Nuchtern, GB Mallory… - Pediatric …, 2020 - Wiley Online Library
OS Eckstein, JG Nuchtern, GB Mallory, RP Guillerman, MA Musick, M Barclay, JM Bhatt
Pediatric pulmonology, 2020Wiley Online Library
Patients with pulmonary Langerhans cell histiocytosis (LCH) typically have a benign course
but may have extensive cystic lung disease with rare life‐threatening complications
including multiple and recurrent pneumothoraces and respiratory failure. We report seven
severely affected pediatric patients treated with chemotherapy, aggressive chest tube
management, and pleurodesis of whom five survived. Patients with extraordinary amounts of
pulmonary cystic disease and multiple pneumothoraces due to LCH can have remarkable …
Abstract
Patients with pulmonary Langerhans cell histiocytosis (LCH) typically have a benign course but may have extensive cystic lung disease with rare life‐threatening complications including multiple and recurrent pneumothoraces and respiratory failure. We report seven severely affected pediatric patients treated with chemotherapy, aggressive chest tube management, and pleurodesis of whom five survived. Patients with extraordinary amounts of pulmonary cystic disease and multiple pneumothoraces due to LCH can have remarkable, curative outcomes with early recognition, optimal LCH‐directed therapy, and supportive care.
Wiley Online Library
以上显示的是最相近的搜索结果。 查看全部搜索结果